DUBAI: BHM Capital, a leading financial institution in the capital markets of the United Arab Emirates, listed on the Dubai Financial Market, is pleased to announce the launch of the Fixed Income Division, this dedicated department, with over 75 years of collective experience, aims to enhance BHM Capital’s position in local and regional financial markets….
Jordanes AS announces NOK 1.5 billion IPO on the Oslo Stock Exchange
OSLO: Jordanes AS, parent company of Jordanes Investments AS, announced its intention to launch an initial public offering (IPO) of its shares and to apply for a listing of its shares on the main list of the Oslo Stock Exchange. Jordanes AS is a well-established Scandinavian brand house that focuses on everyday brands. The Group…
Lifecare AS acquires majority stake in RemovAid AS
BERGEN, NORWAY: Lifecare AS, a pioneering medical sensor company, has announced a significant investment of NOK 2 million in RemovAid AS, securing an 81.1% ownership stake. This strategic move positions Lifecare at the forefront of medical technology innovation, particularly in the Continuous Glucose Monitor (CGM) market. RemovAid, an Oslo-based medtech firm, has gained attention for…
EG Norge to offer NOK 20/share to buy all outstanding shares of Carasent ASA
OSLO, NORWAY: EG Norge AS is contemplating launching a voluntary cash offer to acquire all outstanding shares of Carasent ASA at a price of NOK 20 per share. The offer represents a premium of 81.8% to closing price the last trading day before Carasent ASA published the Q1 2024 report including the revised financial targets…
Aminex secures $3 million funding facility from Eclipse Investments
LONDON: Aminex, a company specializing in exploration and development, has announced the establishment of a $3 million funding facility with Eclipse Investments LLC, its principal shareholder. This strategic financial support is structured to be accessible over a 24-month period, with an initial tranche of $1.5 million guaranteed and the subsequent tranche subject to Eclipse’s discretion….
Smarttech247 signs three-year deal worth USD $2.1 million
LONDON: Smarttech247 (AIM: S247), a multi-award-winning provider of AI-enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients, has signed a new additional contract with an existing pharmaceuticals solutions client worth USD $2.1 million over three years. The contract will utilise Smarttech247’s partnership agreement with Splunk Inc., which brings together …
Thor Explorations announces strong 2023 performance and optimistic outlook
LONDON: Thor Explorations Ltd. has reported a successful operational and financial year for 2023, with significant achievements at its Segilola Gold Mine in Nigeria and exploration properties across Nigeria, Senegal, and Burkina Faso. The company sold 73,356 ounces of gold at an average price of $1,907 per ounce, generating revenue of $141.2 million and an…
Oxford Biomedica reports 36% decline in revenues for 2023
LONDON: Oxford Biomedica plc, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has released its preliminary financial results for the year ending December 31, 2023. Despite a challenging year, the Group has maintained stable core business revenues with a slight increase, although total revenues saw a significant drop of 36% to…
Supermarket Income REIT announces acquisition of Carrefour Supermarket portfolio in France
LONDON: Supermarket Income REIT plc (LSE: SUPR), the real estate investment trust providing secure, inflation-linked, long income from grocery property, announced the acquisition of a portfolio of Carrefour supermarkets in France through a sale and leaseback transaction (“SLB”), for a total purchase price of €75.3 million (excluding acquisition costs), reflecting a net initial yield of…
COMAC secures order for 100 C919 Aircraft from a major airline
LONDON: A major airline company has entered into a significant agreement with the Commercial Aircraft Corporation of China (COMAC) to purchase 100 of the much-anticipated C919 aircraft (Extended-ranged Version). This transaction is set to reshape the future of aviation with the C919 being a direct competitor to the likes of Boeing and Airbus. The deal,…
Aberforth Split Level Income Trust announces winding-up scheme with AGVIT
LONDON: Aberforth Split Level Income Trust plc (ASLIT) Board has outlined a scheme for the company’s voluntary winding-up. The Board has agreed in principle with Aberforth Geared Value & Income Trust plc (AGVIT) on a reconstruction scheme, set to be effective on June 28, 2024, pending shareholder approval. AGVIT, launching on July 1, 2024, will…
EU Panel endorses AstraZeneca’s breast cancer drug Truqap
LONDON: The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AstraZeneca’s drug Truqap, in combination with Faslodex, for treating certain advanced breast cancer cases. The positive opinion is based on the CAPItello-291 Phase III trial results, which showed a 50% reduction in disease progression or death compared…